IMVT
Immunovant, Inc. · Healthcare
Chief Legal Officer Tuyl Christopher Van sold $683K of Immunovant, Inc.
Sold$682,887
$38.31Price
17,824Shares
−9%Stake
What IMVT did after the filing
- The stock from Mon, Jun 29 open, $38.29
- +6.9%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Aug 11 close.
Traded Fri, Jun 26. Filed Fri, Jun 26, 7:45 PM ET, after the close. Returns use the Jun 29 open and the Aug 11 close. Not investment advice.